Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Polymyxin B | 2 | 2020 | 93 | 1.61 | Why? |
| Bronchial Thermoplasty | 2 | 2019 | 14 | 1.49 | Why? |
| Hemoperfusion | 2 | 2020 | 260 | 1.29 | Why? |
| Polystyrenes | 1 | 2020 | 98 | 0.82 | Why? |
| Yellow Nail Syndrome | 1 | 2018 | 5 | 0.77 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 896 | 0.72 | Why? |
| Toluene | 1 | 2017 | 21 | 0.70 | Why? |
| Midazolam | 1 | 2018 | 79 | 0.70 | Why? |
| Clarithromycin | 1 | 2018 | 112 | 0.69 | Why? |
| Erlotinib Hydrochloride | 2 | 2016 | 48 | 0.69 | Why? |
| Hyperbaric Oxygenation | 1 | 2021 | 268 | 0.68 | Why? |
| Hemoptysis | 2 | 2017 | 172 | 0.65 | Why? |
| ErbB Receptors | 2 | 2016 | 320 | 0.65 | Why? |
| Nails | 1 | 2018 | 143 | 0.64 | Why? |
| Aneurysm | 1 | 2017 | 117 | 0.63 | Why? |
| Tuberculosis, Miliary | 1 | 2017 | 66 | 0.63 | Why? |
| Conscious Sedation | 1 | 2018 | 222 | 0.61 | Why? |
| Bronchoscopy | 3 | 2019 | 991 | 0.60 | Why? |
| Cannula | 1 | 2021 | 750 | 0.59 | Why? |
| Foreign Bodies | 1 | 2017 | 171 | 0.55 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.49 | Why? |
| Hypnotics and Sedatives | 1 | 2018 | 624 | 0.48 | Why? |
| Pulmonary Aspergillosis | 1 | 2017 | 408 | 0.47 | Why? |
| Lung Neoplasms | 3 | 2018 | 3228 | 0.44 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.44 | Why? |
| Asthma | 2 | 2019 | 4383 | 0.38 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.36 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.35 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.34 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 595 | 0.34 | Why? |
| Indoles | 1 | 2014 | 1243 | 0.30 | Why? |
| Autopsy | 1 | 2017 | 3495 | 0.30 | Why? |
| Protein Kinase Inhibitors | 2 | 2014 | 1585 | 0.29 | Why? |
| Smoking | 2 | 2019 | 3358 | 0.28 | Why? |
| Enzyme Inhibitors | 1 | 2014 | 1881 | 0.26 | Why? |
| Chemokine CCL17 | 1 | 2020 | 30 | 0.22 | Why? |
| beta 2-Microglobulin | 1 | 2020 | 102 | 0.22 | Why? |
| Kidney Transplantation | 1 | 2021 | 5397 | 0.22 | Why? |
| Embolization, Therapeutic | 2 | 2017 | 269 | 0.21 | Why? |
| Japan | 5 | 2021 | 6653 | 0.21 | Why? |
| Pulmonary Alveolar Proteinosis | 1 | 2019 | 16 | 0.20 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.20 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.20 | Why? |
| Arteries | 1 | 2020 | 283 | 0.18 | Why? |
| Lymphedema | 1 | 2018 | 44 | 0.18 | Why? |
| Patient Comfort | 1 | 2018 | 74 | 0.17 | Why? |
| Mucus | 1 | 2019 | 183 | 0.17 | Why? |
| Pemetrexed | 1 | 2016 | 32 | 0.17 | Why? |
| Injections, Intravenous | 1 | 2018 | 381 | 0.17 | Why? |
| Vital Capacity | 1 | 2019 | 399 | 0.17 | Why? |
| Carboplatin | 1 | 2016 | 76 | 0.16 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.16 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 290 | 0.16 | Why? |
| Maintenance Chemotherapy | 1 | 2016 | 133 | 0.16 | Why? |
| Angiography | 1 | 2017 | 301 | 0.16 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.15 | Why? |
| Aged | 14 | 2021 | 215776 | 0.15 | Why? |
| Forced Expiratory Volume | 1 | 2019 | 632 | 0.15 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.15 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.15 | Why? |
| Male | 16 | 2021 | 367725 | 0.15 | Why? |
| Bevacizumab | 1 | 2016 | 149 | 0.15 | Why? |
| Lung | 4 | 2021 | 31049 | 0.15 | Why? |
| Cisplatin | 1 | 2016 | 209 | 0.15 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.15 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.14 | Why? |
| Intubation, Intratracheal | 2 | 2021 | 3962 | 0.14 | Why? |
| Arthritis, Rheumatoid | 2 | 2018 | 2043 | 0.13 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 1573 | 0.13 | Why? |
| Fungi | 1 | 2017 | 471 | 0.13 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.13 | Why? |
| Pleural Effusion | 1 | 2018 | 680 | 0.12 | Why? |
| Humans | 24 | 2021 | 930598 | 0.12 | Why? |
| Bronchi | 1 | 2019 | 1048 | 0.12 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.11 | Why? |
| Treatment Outcome | 5 | 2017 | 51732 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Sinusitis | 1 | 2018 | 649 | 0.11 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.10 | Why? |
| Female | 14 | 2021 | 380317 | 0.10 | Why? |
| Bucrylate | 1 | 2009 | 3 | 0.10 | Why? |
| Oxygen | 2 | 2020 | 3715 | 0.10 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.10 | Why? |
| Bronchial Arteries | 1 | 2009 | 30 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.10 | Why? |
| Salvage Therapy | 1 | 2012 | 417 | 0.10 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.09 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.08 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.08 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.08 | Why? |
| Autoimmune Diseases | 1 | 2019 | 1996 | 0.07 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Adenocarcinoma | 1 | 2012 | 651 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.07 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Antirheumatic Agents | 1 | 2017 | 3023 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2019 | 191 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Tokyo | 1 | 2021 | 645 | 0.05 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Confidence Intervals | 1 | 2017 | 744 | 0.04 | Why? |
| Administration, Inhalation | 1 | 2019 | 1647 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.03 | Why? |
| Quinazolines | 1 | 2012 | 126 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Autoantibodies | 1 | 2019 | 2094 | 0.02 | Why? |
| Lung Diseases, Fungal | 1 | 2009 | 167 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Aspergillosis | 1 | 2009 | 264 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.02 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Recurrence | 1 | 2009 | 3675 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Sugiyama's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(158)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_